Skip to main content
Erschienen in: European Radiology 9/2013

01.09.2013 | Oncology

Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma

Erschienen in: European Radiology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To analyse the diagnostic accuracy and to establish a predictive score based on diffusion-weighted magnetic resonance imaging (DWMRI) compared to exploratory laparotomy (EL) for predicting suboptimal cytoreductive surgery for different intra-abdominal sites of implants in patients with ovarian cancer.

Methods

Thirty-four patients with advanced ovarian carcinoma were studied. Preoperative DWMRI of the abdomen and pelvis was performed. DWMRI findings were compared with EL. Ten anatomical sites were selected for inclusion in the score. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy for suboptimal cytoreduction were calculated for both DWMRI and EL. Receiver operating characteristic (ROC) curve analysis was used to assess the ability to predict suboptimal cytoreduction.

Results

Using predictive score, ROC curves were generated with an area under the curve of 0.938 for DWMRI and 0.947 for EL (P < 0.0001). For DWMRI, a score ≥6 had the highest overall accuracy at 91.1 % and identified patients with unnecessary EL with a sensitivity of 75 %. For EL, a score ≥4 had the highest overall accuracy at 88.2 % and was able to identify patients with unnecessary EL with a sensitivity of 87.5 %.

Conclusions

DWMRI is an emerging technique that may be useful to predict suboptimal cytoreduction in ovarian cancer.

Key Points

DWMRI is increasingly used in ovarian cancer.
DWMRI is an accurate technique for depicting intra-abdominal sites of implants
DWMRI is useful for predicting optimal cytoreductive surgical outcome.
We report a high predictive value similar to exploratory laparotomy.
Literatur
1.
Zurück zum Zitat Angioli R, Palaia I, Zullo MA et al (2006) Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 100:455–461PubMedCrossRef Angioli R, Palaia I, Zullo MA et al (2006) Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 100:455–461PubMedCrossRef
2.
Zurück zum Zitat Testa AC, Ludovisi M, Mascilini F et al (2012) Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 39:99–105PubMedCrossRef Testa AC, Ludovisi M, Mascilini F et al (2012) Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 39:99–105PubMedCrossRef
3.
Zurück zum Zitat Vergote I, Trope GC, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943–953PubMedCrossRef Vergote I, Trope GC, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943–953PubMedCrossRef
4.
Zurück zum Zitat Chi DS, Zivanovic O, Palayekar MJ et al (2009) A contemporary analysis of the ability of preoperative serum CA125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol 112:6–10PubMedCrossRef Chi DS, Zivanovic O, Palayekar MJ et al (2009) A contemporary analysis of the ability of preoperative serum CA125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol 112:6–10PubMedCrossRef
5.
Zurück zum Zitat Ferrandina G, Sallustio G, Fagotti A et al (2009) Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer 101:1066–1073PubMedCrossRef Ferrandina G, Sallustio G, Fagotti A et al (2009) Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer 101:1066–1073PubMedCrossRef
6.
Zurück zum Zitat Fagotti A, Ferrandina G, Fanfani F et al (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 199:642.e1–642.e6CrossRef Fagotti A, Ferrandina G, Fanfani F et al (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 199:642.e1–642.e6CrossRef
7.
Zurück zum Zitat Brun JL, Rouzier R, Uzan S, Daraï E (2008) External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 110:354–359PubMedCrossRef Brun JL, Rouzier R, Uzan S, Daraï E (2008) External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 110:354–359PubMedCrossRef
8.
Zurück zum Zitat Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540PubMedCrossRef Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540PubMedCrossRef
9.
Zurück zum Zitat Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19:745–760PubMedCrossRef Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19:745–760PubMedCrossRef
10.
Zurück zum Zitat Sala E, Kataoka MY, Priest AN et al (2012) Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology 263:149–159PubMedCrossRef Sala E, Kataoka MY, Priest AN et al (2012) Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology 263:149–159PubMedCrossRef
11.
Zurück zum Zitat Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings—a feasibility study. AJR Am J Roentgenol 193:461–470PubMedCrossRef Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings—a feasibility study. AJR Am J Roentgenol 193:461–470PubMedCrossRef
12.
Zurück zum Zitat Hoskins WJ (1994) Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 55:S91–S96PubMedCrossRef Hoskins WJ (1994) Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 55:S91–S96PubMedCrossRef
13.
Zurück zum Zitat Heintz APM, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD (1986) Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 67:783–788PubMedCrossRef Heintz APM, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD (1986) Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 67:783–788PubMedCrossRef
14.
Zurück zum Zitat Farias-Eisner R, Teng F, Oliveira M et al (1994) The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery. Gynecol Oncol 55:108–110PubMedCrossRef Farias-Eisner R, Teng F, Oliveira M et al (1994) The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery. Gynecol Oncol 55:108–110PubMedCrossRef
15.
Zurück zum Zitat Chi DS, Venkatraman ES, Masson V, Hoskins WJ (2000) The ability of preoperative CA125 to predict optimal primary tumor cytoreduction in Stage III epithelial ovarian carcinoma. Gynecol Oncol 77:227–231PubMedCrossRef Chi DS, Venkatraman ES, Masson V, Hoskins WJ (2000) The ability of preoperative CA125 to predict optimal primary tumor cytoreduction in Stage III epithelial ovarian carcinoma. Gynecol Oncol 77:227–231PubMedCrossRef
16.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 143:29–36PubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 143:29–36PubMed
17.
Zurück zum Zitat Golde JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to the spontaneous mutation rate. Cancer Treat Rep 63:1727–1733 Golde JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to the spontaneous mutation rate. Cancer Treat Rep 63:1727–1733
18.
Zurück zum Zitat Hou JY, Kelly MG, Yu H et al (2007) Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 105:211–217PubMedCrossRef Hou JY, Kelly MG, Yu H et al (2007) Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 105:211–217PubMedCrossRef
19.
Zurück zum Zitat Brockbank E, Ind T, Barton D et al (2004) Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. Int J Gynecol Cancer 14:42–50PubMedCrossRef Brockbank E, Ind T, Barton D et al (2004) Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. Int J Gynecol Cancer 14:42–50PubMedCrossRef
20.
Zurück zum Zitat Memarzadeh S, Lee S, Berek J, Farias-Esner R (2002) Ca125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Obstet Gynecol 100:59–64CrossRef Memarzadeh S, Lee S, Berek J, Farias-Esner R (2002) Ca125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Obstet Gynecol 100:59–64CrossRef
21.
Zurück zum Zitat Fujii S, Matsusue E, Kanasaki Y et al (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18:18–23PubMedCrossRef Fujii S, Matsusue E, Kanasaki Y et al (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18:18–23PubMedCrossRef
22.
Zurück zum Zitat Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 19:1394–1401. Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 19:1394–1401.
23.
Zurück zum Zitat Coakley FV, Choi PH, Gougoutas CA et al (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499PubMedCrossRef Coakley FV, Choi PH, Gougoutas CA et al (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499PubMedCrossRef
24.
Zurück zum Zitat Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068PubMed Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068PubMed
25.
Zurück zum Zitat Kawamoto S, Urban BA, Fishman EK (1999) CT of epithelial ovarian tumors. Radiographics 19:S85–S102PubMed Kawamoto S, Urban BA, Fishman EK (1999) CT of epithelial ovarian tumors. Radiographics 19:S85–S102PubMed
Metadaten
Titel
Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma
Publikationsdatum
01.09.2013
Erschienen in
European Radiology / Ausgabe 9/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2837-7

Weitere Artikel der Ausgabe 9/2013

European Radiology 9/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.